---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-006945"
form_type: "8-K"
ticker: "GTHP"
cik: "0000924515"
company_name: "GUIDED THERAPEUTICS INC"
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:35:56.922027+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Guided Therapeutics closes $3.3M bridge financing, exchanges Auctus debt, targets FDA study completion

## Summary
- Raised ~$3.3M via 6.6M shares at $0.50 each, plus four-year warrants for 6.6M shares at $0.50 and 6.6M at $0.65.
- Auctus exchanged $1.06M debt and 8.78M warrants for $1.95M in units (3.9M shares, 3.9M warrants at $0.50 and $0.65); residual $490K debt over 18 months.
- Net proceeds ~$3.2M; primary use to fund clinical study data for FDA approval of LuViva Advanced Cervical Scan, also support international sales and reduce debt.
- Stockholders' equity nearly break-even; Company to withdraw S-1/A for Nasdaq uplist and reapply when market conditions improve.
- Investors include board members Richard Blumberg, Michael James, John Imhoff.

## SEC filing metadata
- accession: 0001477932-22-006945
- form_type: 8-K
- ticker: GTHP
- cik: 0000924515
- company_name: GUIDED THERAPEUTICS INC
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/924515/000147793222006945/0001477932-22-006945-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/924515/000147793222006945/gthp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-006945
- JSON: https://secwatch.observer/filing/0001477932-22-006945.json
- Plain text: https://secwatch.observer/filing/0001477932-22-006945.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.